New & Notable
Advancing sustainability in biopharmaceutical manufacturing
Sustainable biopharmaceutical manufacturing is adopting green technologies to minimize waste, optimize processes and uphold product quality amid regulatory and environmental challenges.
Understanding PMBs' role and impact on drug pricing
PBMs shape drug pricing and healthcare costs, but growing market consolidation sparks concerns about less competition, higher prices and fewer options for patients.
Hurricane Helene triggers dialysis and IV fluid shortage
Following Hurricane Helene, damages to a manufacturing plant in North Carolina and subsequent nationwide IV fluid shortages have forced manufacturers to mobilize global networks.
Medicare drug price negotiations impact non-chain pharmacies
Although Medicare drug price negotiations intend to expand medication access, independent pharmacies are facing challenges associated with reimbursement and PBM strategies.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All Reports
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
PBMs call for FTC commissioners' recusal from antitrust case
Cigna, UnitedHealth and CVS Caremark are requesting FTC commissioners step down from a PBM lawsuit, alleging prejudgment and bias in the agency's review process.
-
FDA authorizes combined at-home flu, COVID-19 tests outside EUA
The Healgen Rapid Check COVID-19/Flu A&B Antigen Test is the first combined at-home flu and COVID tests to be authorized by the FDA through traditional premarket review.
-
WHO clears in vitro diagnostic mpox testing for emergency use
After declaring a global health emergency for mpox, the WHO has issued an Emergency Use Listing for an in vitro diagnostic test for early mpox diagnosis and treatment.
-
FDA announces the Human Foods Program is in effect
The FDA's Human Foods Program is officially in effect as of October 1, 2024, focusing on priorities such as microbiological food safety, food chemical safety and nutrition.
-
FDA approves self-administered nasal influenza vaccine
By the 2025-2026 respiratory virus season, FluMist, the nasal influenza vaccine, will be available for home vaccination via self- or caregiver-administration to eligible patients.
-
FTC sues PBMs, affiliated GPOs for inflating insulin prices
Caremark Rx, Express Scripts, and OptumRx are facing legal repercussions after the FTC accused them of insulin price inflation in a lawsuit announced on Sept. 20, 2024.
Features
-
Exploring emerging breast cancer screening tools, technology
New breast cancer screening tools, ranging from 3D mammography to AI-assisted screening analysis play a critical role in the evolving breast cancer screening landscape.
-
Climate change drives drug demand for chronic conditions
As climate change intensifies, the pharmaceutical industry faces a new challenge: rising drug demand for climate-sensitive chronic conditions amid more frequent extreme weather events.
-
What would a CVS Health breakup mean for stakeholders?
Antonio Ciaccia discusses what a CVS Health breakup could look like and what that would mean for the pharmaceutical marketplace and various stakeholders.
-
Are compounded GLP-1 drugs safe?
Growing demand for GLP-1 weight loss drugs has caused market shortages, prompting compounding pharmacies to offer alternatives that raise safety and reliability issues.